Increased incidence of coronary in-stent restenosis in type 2 diabetic patients is related to elevated serum malondialdehyde-modified low-density lipoprotein

Circulation Journal

Volumn 71, Issue 11, 2007, Pages 1697-1702

  Shigematsu, Sakuji ^a   Takahashi, Naohiko ^b   Hara, Masahide ^b   Yoshimatsu, Hironobu ^b   Saikawa, Tetsunori ^b  

^a NATIONAL HOSPITAL ORGANIZATION BEPPU MEDICAL CENTER   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

Angioplasty; Diabetes mellitus; Lipids; Restenosis; Stents

Indexed keywords

ACETYLSALICYLIC ACID; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; TICLOPIDINE;

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CODING; RESTENOSIS; RISK FACTOR; THROMBOSIS;

AGED; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; RISK FACTORS; STENTS; TUNICA INTIMA;

EID: 36949032972     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1697     Document Type: Article

References (36)

1. Kastrati A. Schoemig A. Elezi S, Schulden H, Dirschinger J. Hadamitzky M. et al. Predictive factors of restenosis after corollary stent placement. J Am Coll Cardiol 1997; 30: 1428-1436.
2. Bauters C. Hubert E. Prat A. Bougrimi K, Van Belle E, McFadden EP. et al. Predictors of restenosis alter coronary stent implantation. J Am Coll Cardiol 1998; 31: 1291-1298.
3. Mazeika P. Prasad N. Bui S. Seidelin PH. Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus. Am Heart J 2003; 145: 1013-1021.
4. Hoffman R. Mintz GS. Dussaillant GR, Popma JJ, Pichard AD, Satler LF. et al. Patterns and mechanism of in-stent restenosis: A serial intravascular ultrasound study. Circulation 1996; 94: 1247-1254.
5. Elezi S. Kastrati A. Pache J. Wehinger A, Hadamitzky M. Dirschinger J. et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998; 32: 1866-1873.
6. Schofer J. Schluter M. Rau T. Hammer F, Haag N, Mathey DG. Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: A controlled study. J Am Coll Cardiol 2000; 35: 1554-1559.
7. Faries PL. Rohan DI. Takahara H, Wyers MC, Contreras MA, Quist WC. et al. Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg 2001; 33: 601-607.
8. Park SH. Marso SP. Zhou Z. Foroudi F, Topol EJ, Lincoff AM. Neointimal hyperplasia following arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus. Circulation 2001; 104: 815-819.
9. Aronson D. Bloomgarden Z. Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 1996; 27: 528-535.
10. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795.
11. Berliner JA. Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20: 707-727.
12. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272: 20963-20966.
13. Shen CM. Mao SJ. Huang GS, Yang PC, Chu RM. Stimulation of smooth muscle cell proliferation by ox-LDL- and acetyl LDL-induced macrophage-derived foam cells. Life Sci 2001; 70: 443-452.
14. Yamakawa T. Eguchi S. Yamakawa Y, Motley ED, Numaguchi K. Utsunomiya H. et al. Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells. Hypertension 1998; 31: 248-523.
15. Holvoet P. Mertens A. Verhamme P, Bogaerts K, Beyens G. Verhaeghe R. et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001; 21: 844-848.
16. Tsuzura S. Ikeda Y. Suehiro T. Ota K, Osaki F, Arii K, et al. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 2004; 53: 297-302.
17. Shimada K. Mokuno H. Matsunaga E, Miyazaki T, Sumiyoshi K. Kume A. et al. Predictive value of circulating oxidized LDL for cardiac events in type 2 diabetic patients with coronary artery disease. Diabetes Care 2004; 27: 843-844.
18. Kotani K. Maekawa M. Kanno T, Kondo A, Toda N, Manabe M. Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Biochim Biophys Acta 1994; 1215: 121-125.
19. Kitano S. Kanno T. Maekawa M, Sakurabayashi I, Kotani K. Hisatomi H. et al. Improved method for the immunological detection of malondialdehyde-modified low-density lipoproteins in human serum. Anal Chim Acta 2004; 509: 229-235.
20. Stein B. Weintraub WS. Gebhart SP, Cohen-Bernstein CL. Grosswald R. Liberman HA et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995; 91: 979-989.
21. Abizaid A. Kornowski R. Mintz GS, Hong MK, Abizaid AS, Mehran R. et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998; 32: 584-589.
22. Van Belle E. Perie M. Braune D, Chmait A, Meurice T, Abolmaali K. et al. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 2002; 40: 410-417.
23. Kornowski R. Mintz GS. Kent KM, Pichard AD, Satler LE, Bucher TA. et al. Increased restenosis in diabetes mellitus after interventions is due to exaggerated intimal hyperplasia: Arterial intravascular ultrasound study. Circulation 1997; 95: 1366-1369.
24. Kip KE. Faxon DP. Detre KM. Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients: The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996; 94: 1818-1825.
25. Zhou Z. Wang K. Penn MS. Marso SP, Lauer MA, Forudi F, et al. Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation 2003; 107: 2238-2243.
26. Indolfi C. Torella D. Cavuto L. Davalli AM, Coppola C, Esposito G. et al. Effects of balloon injury on neointimal hyperplasia in streptozocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation 2001; 103: 2980-2986.
27. Suselbeck T. Latsch A. Siri H. Gonska B, Poerner T, Pfleger S, et al. Role of vessel size as a predictor for the occurrence of in-stent restenosis in patients with diabetes mellitus. Am J Cardiol 2001; 88: 243-247.
28. Schomig A. Kastrati A. Dietz R, Rauch B, Neumann FJ, Katus HH. et al. Emergency coronary stenting for dissection during percutaneous transluminal coronary angioplasty: Angiographic follow-up after stenting and after repeat angioplasty of the stented segment. J Am Coll Cardiol 1994; 23: 1053-1060.
29. Steinberg D. Role of oxidized LDL and antioxidants in atherosclerosis. Adv Exp Med Biol 1995; 369: 39-48.
30. Jessup W. Kritharides L. Metabolism of oxidized LDL by macrophages. Curr Opin Lipidol 2000; 11: 473-481.
31. Tanaga K. Bujo H. Inoue M. Mikami K, Kotani K, Takahashi K, et al. Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles. Arterioscler Thromb Vasc Biol 2002; 22: 662-666.
32. Austin MA. Breslow JL. Hennekens CH, Buring JE, Willett WC. Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917-1921.
33. Kondo A. Manabe M. Saito K. Maekawa M, Kanno T. Insulin treatment prevents LDL from accelerated oxidation in patients with diabetes. J Atheroscler Thromb 2002; 9: 280-287.
34. Kobayashi T. Matsumoto T. Kamata K. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats. Br J Pharmacol 2000; 131: 231-238.
35. Abdel-Wahab MH. Abd-Allah AR. Possible protective effect of melatonin and/or desferrioxamine against streptozotocin-induced hyperglycaemia in mice. Pharmacol Res 2000; 41: 533-537.
36. Yang CM. Chien CS. Hsiao LD. Pan SL, Wang CC, Chiu CT, et al. Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway. Br J Pharmacol 2001; 132: 1531-1541.